Executives
-
Clark James DavidSVP, Cont & Chief Acct Officer -
Nelson Steven HEVP and President, Aetna
-
Joyner J. DavidPresident and CEO
-
Shah Prem SEVP and Group President
-
Mandadi TilakEVP, Chief DDAT Officer
-
Chaguturu Sreekanth KEVP and Chief Medical Officer
-
Havanec Laurie P.EVP and Chief People Officer
-
Kane Brian AEVP/President, Aetna
-
Khichi Samrat S.EVP, CPO and General Counsel
-
Cowhey Thomas F.EVP and CFO
-
Lynch Karen SPresident and CEO
Board Directors
-
Finucane Anne A.Director
-
Farah Roger NDirector
-
Robbins LarryDirector
-
Shulman Douglas H.Director
-
Schapiro Mary LDirector
-
Millon Jean PierreDirector
-
Mahoney Michael FDirector
-
Kirby J ScottDirector
-
Deparle Nancy AnnDirector
-
Decoudreaux Alecia ADirector
-
Brown C David IiDirector
-
Balser Jeffrey R.Director
-
Aguirre FernandoDirector
-
Ludwig Edward JDirector
?
Mandadi Tilak
EVP, Chief DDAT Officer
CVS Health Corporation
US, Woonsocket [HQ]
CIK
1872827
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
40,414
Price per Share :
$52.62
Equivalence :
$2,126,584.68
Transaction History
-
F40,414 Shares After TransactionValue : $2,313,297.36$749,672.28Transaction Date : 08/31/24
-
Footnotes
-
-
Footnotes:#1 Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
-
A99,747 Shares After TransactionValue : $5,969,857.95$2,999,981.25Transaction Date : 11/30/24
-
Footnotes
-
-
Footnotes:#1 Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 11/30/2025.
-
A82,904 Shares After TransactionValue : $n/a$0.0Transaction Date : 04/01/24
-
Footnotes
-
-
Footnotes:#1 Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025.